Key result
Transcatheter therapy expands options for high-risk multiple VHD despite unclear impacts of isolated interventions.
Why the study?
Existing guidelines emphasize single valvular dysfunction, and the impact of isolated transcatheter valve therapies on patients with multiple valvular heart disease is not well understood.
This review highlights the diagnostic challenges and therapeutic considerations for managing multiple valvular heart disease in the era of expanding transcatheter therapies.
May inform transcatheter decisions in high-risk multiple valve disease; leaves open effects of isolated interventions.
Although existing guidelines offer strong recommendations for single valvular dysfunction, the growing prevalence of multiple valvular heart disease (MVHD) in our aging population is challenging the clarity of clinical guidance. Traditional diagnostic modalities, such as echocardiography, face inherent constraints in precisely quantifying valvular dysfunction due to the hemodynamic interactions that occur with multiple valve involvement. Therefore, many patients with MVHD present at a later stage in their disease course and with an elevated surgical risk. The expansion of transcatheter therapy for the treatment of valvular heart disease has added new opportunities for higher-risk patients. However, the impact of isolated valve therapies on patients with MVHD is still not well understood. This review focuses on the etiology, diagnostic challenges, and therapeutic considerations for some of the most common concomitant valvular abnormalities that occur in our daily clinic population.
No takes yet. Share an insight, caveat, or question.
Basman et al. (2024) conducted a review in Multiple valvular heart disease. Transcatheter therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: